{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:42:06Z","timestamp":1791996126861,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06785-w","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T14:02:10Z","timestamp":1663509730000},"page":"1145-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia"],"prefix":"10.1007","volume":"307","author":[{"given":"Chanya","family":"Rakprasit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ruengkhachorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwanit","family":"Therasakvichya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perapong","family":"Inthasorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuthinun","family":"Achariyapota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sompop","family":"Kuljarasnont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khemanat","family":"Khemworapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-6613","authenticated-orcid":false,"given":"Nida","family":"Jareemit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"6785_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","volume":"4","author":"A Altieri","year":"2003","unstructured":"Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C (2003) Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4:670\u2013678","journal-title":"Lancet Oncol"},{"key":"6785_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.6061\/clinics\/2017(05)05","volume":"72","author":"FTC Asmar","year":"2017","unstructured":"Asmar FTC, Braga-Neto AR, de Rezende-Filho J, Villas-Boas JMS, Charry RC, Maesta I (2017) Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study. Clinics 72:284\u2013288","journal-title":"Clinics"},{"key":"6785_CR3","first-page":"591","volume":"41","author":"A Ayhan","year":"1996","unstructured":"Ayhan A, Tuncer ZS, Halilzade H, Kucukali T (1996) Predictors of persistent disease in women with complete hydatidiform mole. J Reprod Med 41:591\u2013594","journal-title":"J Reprod Med"},{"key":"6785_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0140-6736(86)90179-0","volume":"2","author":"KD Bagshawe","year":"1986","unstructured":"Bagshawe KD, Dent J, Webb J (1986) Hydatidiform mole in England and wales 1973\u201383. Lancet 2:673\u2013677","journal-title":"Lancet"},{"key":"6785_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.fertnstert.2015.06.001","volume":"104","author":"M Bakhtiyari","year":"2015","unstructured":"Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-Vand S, Sarfjoo FS (2015) Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors. Fertil Steril 104:649\u2013654","journal-title":"Fertil Steril"},{"key":"6785_CR6","first-page":"81","volume":"43","author":"RS Berkowitz","year":"1998","unstructured":"Berkowitz RS, Im SS, Bernstein MR, Goldstein DP (1998) Gestational trophoblastic disease. subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 43:81\u201386","journal-title":"J Reprod Med"},{"key":"6785_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","volume":"360","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP (2009) Clinical practice. molar pregnancy. N Engl J Med 360:1639\u20131645","journal-title":"N Engl J Med"},{"key":"6785_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","volume":"112","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP (2009) Current management of gestational trophoblastic diseases. Gynecol Oncol 112:654\u2013662","journal-title":"Gynecol Oncol"},{"key":"6785_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2012.07.116","volume":"128","author":"RS Berkowitz","year":"2013","unstructured":"Berkowitz RS, Goldstein DP (2013) Current advances in the management of gestational trophoblastic disease. Gynecol Oncol 128:3\u20135","journal-title":"Gynecol Oncol"},{"issue":"336","key":"6785_CR10","first-page":"331","volume":"215","author":"A Braga","year":"2016","unstructured":"Braga A, Maesta I, Rocha Soares R, Elias KM, Custodio Domingues MA, Barbisan LF, Berkowitz RS (2016) Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Am J Obstet Gynecol 215(336):331\u2013336","journal-title":"Am J Obstet Gynecol"},{"key":"6785_CR11","first-page":"597","volume":"39","author":"P Cavoretto","year":"2020","unstructured":"Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, Valsecchi L, Candiani M, Seckl MJ (2020) A pictorial ultrasound essay of gestational trophoblastic disease. J Ultrasound Med Off J Am Inst Ultrasound Med 39:597\u2013613","journal-title":"J Ultrasound Med Off J Am Inst Ultrasound Med"},{"issue":"3","key":"6785_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","volume":"77","author":"FO Committee","year":"2000","unstructured":"Committee FO (2000) FIGO staging for gestational trophoblastic neoplasia, 2000 FIGO oncology committee. Int J Gynaecol Obstet Off Organ Intern Fed Gynaecol Obstet 77(3):285\u2013287","journal-title":"Int J Gynaecol Obstet Off Organ Intern Fed Gynaecol Obstet"},{"key":"6785_CR13","first-page":"187","volume":"61","author":"EJ Diver","year":"2016","unstructured":"Diver EJ, Horowitz NS, Goldstein DP, Bernstein M, Berkowitz RS, Growdon WB (2016) Timing of referral to the New England trophoblastic disease center: does referral with molar pregnancy versus postmolar gestational trophoblastic neoplasia affect outcomes? J Reprod Med 61:187\u2013191","journal-title":"J Reprod Med"},{"key":"6785_CR14","first-page":"254","volume":"57","author":"KM Elias","year":"2012","unstructured":"Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS (2012) Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med 57:254\u2013258","journal-title":"J Reprod Med"},{"issue":"417","key":"6785_CR15","first-page":"e411","volume":"200","author":"E Garavaglia","year":"2009","unstructured":"Garavaglia E, Gentile C, Cavoretto P, Spagnolo D, Valsecchi L, Mangili G (2009) Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia. Am J Obstet Gynecol 200(417):e411-415","journal-title":"Am J Obstet Gynecol"},{"key":"6785_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1447-0756.2012.01981.x","volume":"39","author":"M Hasanzadeh","year":"2013","unstructured":"Hasanzadeh M, Sharifi N, Esmaieli H, Daloee MS, Tabari A (2013) Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia. J Obstet Gynaecol Res 39:572\u2013577","journal-title":"J Obstet Gynaecol Res"},{"key":"6785_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2021.09.016","volume":"163","author":"YM Hoeijmakers","year":"2021","unstructured":"Hoeijmakers YM, Eysbouts YK, Massuger L, Dandis R, Inthout J, van Trommel NE, Ottevanger PB, Thomas CMG, Sweep F (2021) Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement. Gynecol Oncol 163:531\u2013537","journal-title":"Gynecol Oncol"},{"key":"6785_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00004347-199310000-00006","volume":"12","author":"MD Jeffers","year":"1993","unstructured":"Jeffers MD, O\u2019Dwyer P, Curran B, Leader M, Gillan JE (1993) Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis. Intern J Gynecol Pathol Off J Intern Soc Gynecol Pathol 12:315\u2013323","journal-title":"Intern J Gynecol Pathol Off J Intern Soc Gynecol Pathol"},{"key":"6785_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ygyno.2011.10.035","volume":"124","author":"WD Kang","year":"2012","unstructured":"Kang WD, Choi HS, Kim SM (2012) Prediction of persistent gestational trophoblastic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Gynecol Oncol 124:250\u2013253","journal-title":"Gynecol Oncol"},{"key":"6785_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1479-828X.2009.01085.x","volume":"49","author":"SK Khoo","year":"2009","unstructured":"Khoo SK, Baartz D, Sidhu M, Yip WL, Tripcony L (2009) Analysis of risk factors for persistent gestational trophoblastic disease. Aust N Z J Obstet Gynaecol 49:657\u2013659","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"6785_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejogrb.2011.10.003","volume":"160","author":"BW Kim","year":"2012","unstructured":"Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH (2012) Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Eur J Obstet Gynecol Reprod Biol 160:100\u2013105","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6785_CR22","first-page":"819","volume":"52","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Na YJ, Jung SG, Kim CJ, Bae SN, Lee C (2007) Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience. J Reprod Med 52:819\u2013830","journal-title":"J Reprod Med"},{"key":"6785_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/IGC.0b013e31829703ea","volume":"23","author":"C Lybol","year":"2013","unstructured":"Lybol C, Sweep FC, Ottevanger PB, Massuger LF, Thomas CM (2013) Linear regression of post-evacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia. Intern J Gynecol Cancer Off J Intern Gynecol Cancer Soc 23:1150\u20131156","journal-title":"Intern J Gynecol Cancer Off J Intern Gynecol Cancer Soc"},{"key":"6785_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ygyno.2006.10.012","volume":"104","author":"J Menczer","year":"2007","unstructured":"Menczer J, Schreiber L, Berger E, Golan A, Levy T (2007) Assessment of Her-2\/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia. Gynecol Oncol 104:675\u2013679","journal-title":"Gynecol Oncol"},{"key":"6785_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/494695","volume":"2014","author":"AS Mousavi","year":"2014","unstructured":"Mousavi AS, Karimi S, Modarres Gilani M, Akhavan S, Rezayof E (2014) Does post-evacuation beta -human chorionic gonadotropin level predict the persistent gestational trophoblastic neoplasia? ISRN Obstet Gynecol 2014:494695","journal-title":"ISRN Obstet Gynecol"},{"issue":"Suppl 2","key":"6785_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijgo.12615","volume":"143","author":"HYS Ngan","year":"2018","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L (2018) Update on the diagnosis and management of gestational trophoblastic disease. Intern J Gynaecol Obstet Off Organ Intern Fed Gynaecol Obstet 143(Suppl 2):79\u201385","journal-title":"Intern J Gynaecol Obstet Off Organ Intern Fed Gynaecol Obstet"},{"key":"6785_CR27","first-page":"155","volume":"39","author":"JR Palmer","year":"1994","unstructured":"Palmer JR (1994) Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 39:155\u2013162","journal-title":"J Reprod Med"},{"key":"6785_CR28","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3892\/ol.2016.5074","volume":"12","author":"P Sun","year":"2016","unstructured":"Sun P, Wu Q, Ruan G, Zheng X, Song Y, Zhun J, Wu L, Gotlieb WH (2016) Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia. Oncol Lett 12:3135\u20133142","journal-title":"Oncol Lett"},{"key":"6785_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.placenta.2019.02.004","volume":"77","author":"A Vanichtantikul","year":"2019","unstructured":"Vanichtantikul A, Hodge KG, Somparn P, Saethang T, Triratanachat S, Pisitkun T, Lertkhachonsuk R (2019) Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles. Placenta 77:58\u201364","journal-title":"Placenta"},{"key":"6785_CR30","first-page":"CD007289","volume":"9","author":"Q Wang","year":"2017","unstructured":"Wang Q, Fu J, Hu L, Fang F, Xie L, Chen H, He F, Wu T, Lawrie TA (2017) Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 9:CD007289","journal-title":"Cochrane Database Syst Rev"},{"key":"6785_CR31","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/01.AOG.0000174583.51617.25","volume":"106","author":"AJ Wolfberg","year":"2005","unstructured":"Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E (2005) Post-evacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol 106:548\u2013552","journal-title":"Obstet Gynecol"},{"key":"6785_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0002-9378(12)90820-0","volume":"168","author":"KA Yedema","year":"1993","unstructured":"Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, Thomas CM (1993) Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 168:787\u2013879","journal-title":"Am J Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06785-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06785-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06785-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T08:07:04Z","timestamp":1679040424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06785-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["6785"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06785-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no personal or professional conflicts of interest, and no financial support from the companies that produce and\/or distribute the drugs, devices, or materials described in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Siriraj Institutional Review Board (SIRB) of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (COA No. Si 167\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent statement is not applicable for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}